Search Results - "Smith, Kathleen J."

Refine Results
  1. 1

    Eruptive Keratoacanthoma‐Type Squamous Cell Carcinomas in Patients Taking Sorafenib for the Treatment of Solid Tumors by SMITH, KATHLEEN J., HALEY, HEATHER, HAMZA, SATE, SKELTON, HENRY G.

    Published in Dermatologic surgery (01-11-2009)
    “…BACKGROUND Protein kinases (PKs) are indispensable for most cellular processes, and deregulation of PKs can lead to activation of oncogenic and anti‐apoptotic…”
    Get full text
    Journal Article
  2. 2

    Nuclear expression of the antiapoptotic protein survivin in malignant melanoma by Ding, Yiling, Prieto, Victor G., Zhang, Peter S., Rosenthal, Seth, Smith, Kathleen J., Skelton, Henry G., Diwan, A. Hafeez

    Published in Cancer (01-03-2006)
    “…BACKGROUND Expression of the antiapoptotic protein survivin has been demonstrated in some melanocytic lesions and is believed to be required for melanoma cell…”
    Get full text
    Journal Article
  3. 3

    Polycystic ovary syndrome (PCOS) with melanocytic mucosal macules: the role of STK11 gene polymorphisms in PCOS and Peutz-Jeghers syndrome by Smith, Kathleen J., Germain, Marguerite

    Published in International journal of dermatology (01-02-2016)
    “…Background Polycystic ovary syndrome (PCOS) is a complex genetic disorder that is the most common endocrinopathy that affects women. Observations We report two…”
    Get full text
    Journal Article
  4. 4

    Lichen planus associated with hepatitis C virus: no viral transcripts are found in the lichen planus, and effective therapy for hepatitis C virus does not clear lichen planus by Harden, MAJ David, Skelton, Henry, Smith, COL Kathleen J

    “…Although hepatitis C virus (HCV) was not discovered until 1989, it was recognized for many years that a viral agent was responsible for many cases of…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Leflunomide: an immune modulating drug that may have a role in controlling secondary infections with review of its mechanisms of action by Smith, Kathleen J, Germain, Marguerite

    Published in Journal of drugs in dermatology (01-03-2015)
    “…Leflunomide (LEF) is an immune modulator used most commonly for rheumatoid arthritis (RA). The mechanisms of action of LEF also include anti-microbial effects,…”
    Get more information
    Journal Article
  7. 7

    Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients by Smith, Kathleen J, Hamza, Sate, Skelton, Henry

    Published in Dermatologic surgery (01-04-2004)
    “…In organ transplant recipients (OTR) there is an increased incidence of cutaneous squamous cell carcinomas (CSCC), and they may be aggressive. We wanted to…”
    Get full text
    Journal Article
  8. 8

    Chemical warfare agents: their past and continuing threat and evolving therapies. Part I of II by Smith, Kathleen J, Skelton, Henry

    Published in Skinmed (01-07-2003)
    “…Chemical warfare agents are potentially accessible to even underdeveloped nations because they are easily and inexpensively produced. This means that they are…”
    Get more information
    Journal Article
  9. 9

    Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor α receptor IgG1-Fc fusion complex therapy by Smith, Kathleen J., Skelton, Henry G.

    “…Tumor necrosis factor α (TNF-α) is now believed to be a major contributor to the pathogenesis of the synovitis and joint destruction in rheumatoid arthritis…”
    Get full text
    Journal Article
  10. 10

    Molluscum contagiosum: recent advances in pathogenic mechanisms, and new therapies by Smith, Kathleen J, Skelton, Henry

    “…Two poxviruses, Molluscum contagiosum virus (MCV) and Variola virus are specific to humans. MCV is present worldwide and is directly passed by direct skin to…”
    Get full text
    Journal Article
  11. 11

    Squamous Cell Carcinoma in Situ (Bowen's Disease) in Renal Transplant Patients Treated with 5% Imiquimod and 5% 5‐Fluorouracil Therapy by Smith, Kathleen J., Germain, Margeruite, Skelton, Henry

    Published in Dermatologic surgery (01-06-2001)
    “…Background. Depending upon the patient's age at transplant, skin type, sun exposure, and the need for immunosuppressive therapy to prevent rejection, there is…”
    Get full text
    Journal Article
  12. 12

    Topical 5% imiquimod for the therapy of actinic cheilitis by Smith, Kathleen J., Germain, Margeruite, Yeager, Josef, Skelton, Henry

    “…Background: Tissue-destructive and more selective cytotoxic therapies are the main methods used to treat actinic cheilitis. A topical immune stimulant, 5%…”
    Get full text
    Journal Article
  13. 13

    Microcystic adnexal carcinoma: An immunohistochemical study including markers of proliferation and apoptosis by SMITH, Kathleen J, WILLIAMS, John, CORBETT, David, SKELTON, Henry

    Published in The American journal of surgical pathology (01-04-2001)
    “…Microcystic adnexal carcinoma (MAC) is the prototype for a subset of locally aggressive adnexal carcinomas (LAACs). Ultraviolet radiation (UVR) and UVB…”
    Get full text
    Journal Article
  14. 14

    Basaloid follicular hamartomas associated with autoimmune disease: a possible role for retinoids in therapy by Smith, Kathleen J, Skelton, Henry

    “…A basaloid follicular hamartoma (BFH) may be localized or diffuse. It may also be congenital or acquired. Development of diffuse BFHs has been associated with…”
    Get full text
    Journal Article
  15. 15

    Bowen's Disease (Squamous Cell Carcinoma In Situ) in Immunosuppressed Patients Treated with Imiquimod 5% Cream and a COX Inhibitor, Sulindac: Potential Applications for This Combination of Immunotherapy by Smith, Kathleen J., Germain, Margeruite, Skelton, Henry

    Published in Dermatologic surgery (01-02-2001)
    “…Background. Patients with chronic lymphocytic leukemia (CLL) often have a protracted course. However, all these patients are immunosuppressed and may have a…”
    Get full text
    Journal Article
  16. 16

    Hair follicle nevus in a distribution following Blaskho's lines by Germain, Marguerite, Smith, Kathleen J.

    “…We present a case of a rare follicular hamartoma, a hair follicle nevus. Although most previous reports have been solitary lesions, the case we are reporting…”
    Get full text
    Journal Article
  17. 17

    Histopathologic features seen with radiation recall or enhancement eruptions by SMITH, Kathleen J, GERMAIN, Marguerite, SKELTON, Henry

    Published in Journal of cutaneous medicine and surgery (01-11-2002)
    “…Although a radiation recall or enhancement eruption has been associated with a number of chemotherapeutic drugs, the histologic features have rarely been…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Dermatofibrosarcoma protuberans and giant cell fibroblastoma exhibit CD99 positivity by Diwan, A. Hafeez, Skelton III, Henry G., Horenstein, Marcelo G., Kelly, David R., Barrett, Terry L., Bussian, Anne H., Sanders, Deborah Y., Lazar, Alexander J. F., Prieto, Victor G., Smith, Kathleen J.

    Published in Journal of cutaneous pathology (01-07-2008)
    “…According to most authors, dermatofibrosarcoma protuberans (DFSP) and giant cell fibroblastoma (GCF) represent the adult and juvenile forms, respectively, of…”
    Get full text
    Journal Article